MELI vs UNH: Which Is the Better Buy?
Side-by-side comparison of MercadoLibre, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-09.
MercadoLibre, Inc. · Consumer Cyclical
$1,632.52
+45.0% upside to fair value
Grade B
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$353.52
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH trades at a lower forward P/E
(26.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MELI |
UNH |
| Current Price |
$1,632.52 |
$353.52 |
| Fair Value Estimate |
$2,367.15 |
$512.60 |
| Upside to Fair Value |
+45.0%
|
+45.0%
|
| Market Cap |
$82.8B |
$320.9B |
| Forward P/E |
43.1x
|
26.7x
|
| EV / EBITDA |
22.5x
|
16.1x
|
| Price / Sales |
2.7x
|
0.7x
|
| Price / FCF |
7.2x
|
16.3x
|
| Revenue Growth YoY |
+30.0%
|
+2.0%
|
| Gross Margin |
45.5%
|
18.8%
|
| Operating Margin |
9.9%
|
4.2%
|
| Return on Equity |
29.6%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
13.89%
|
6.13%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
MercadoLibre, Inc. operates a leading e-commerce and fintech platform in Latin America, combining a dominant commerce marketplace with a rapidly growing fintech segment. The company benefits from a durable competitive moat driven by network effects, strong brand recognition, and a comprehensive logistics infrastructure. Despite a recent earnings growth decline of 15.6% in the most recent quarter,…
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% y…
Accumulation Zones
| Metric |
MELI |
UNH |
| Zone Low |
$1,775.36 |
$384.45 |
| Zone High |
$2,012.08 |
$435.71 |
| In Buy Zone? |
Yes
|
Yes
|